"
Team:LMU-Munich
From 2010.igem.org
(Difference between revisions)
| (47 intermediate revisions not shown) | |||
| Line 1: | Line 1: | ||
<!-- Include the next line at the beginning of every page --> | <!-- Include the next line at the beginning of every page --> | ||
{{:Team:LMU-Munich/Templates/Page Header}} | {{:Team:LMU-Munich/Templates/Page Header}} | ||
| - | |||
<html> | <html> | ||
| - | <table width=" | + | <table width="760" border="0" cellspacing="0" cellpadding="0"> |
<tr> | <tr> | ||
| - | <td | + | <td align="center" bgcolor="#FFFFFF" valign=top> |
| - | + | ||
| - | + | <table border="0" cellspacing="2" cellpadding="2"> | |
| - | <table | + | |
<tr> | <tr> | ||
| - | + | ||
| - | < | + | <td rowspan="2" valign="top"><img src="http://igem.semicolonsoftware.de/mediawiki/images/e/e3/ApoSymbol.jpg" /> |
| - | + | ||
</td> | </td> | ||
| - | <td height="0" valign="top"><img src="http://igem.semicolonsoftware.de/mediawiki/images/ | + | <td height="0" valign="top"><img src="http://igem.semicolonsoftware.de/mediawiki/images/5/54/P1-Headernew.gif" /> |
</td> | </td> | ||
</tr> | </tr> | ||
| Line 24: | Line 20: | ||
<table width="100%" border="0" cellspacing="3" cellpadding="3"> | <table width="100%" border="0" cellspacing="3" cellpadding="3"> | ||
<tr> | <tr> | ||
| - | <td><span style="text-align:justify"></html> | + | <td><span style="text-align:justify"></html> |
| + | [[image:Apologo.png|200px|center|ApoControl logo]] | ||
| + | ApoControl Biobrick Library: Possibilities of utilizing apoptosis as a clean and effective selection mark for manipulation in eucaryotic systems. Serves the improving of gen-expression in cell lines and the curtailing of cloning processure for large-scale screening. [[Team:LMU-Munich/ApoControl|more]]<html></span> | ||
</td> | </td> | ||
</tr> | </tr> | ||
| Line 33: | Line 31: | ||
<br /> | <br /> | ||
| - | <table | + | <table border="0" cellspacing="2" cellpadding="2" > |
<tr> | <tr> | ||
| - | + | ||
<td width="151" rowspan="2" valign="top"><img src="http://igem.semicolonsoftware.de/mediawiki/images/a/ab/Pathway-Symbol.jpg" width="149" height="141" /></td> | <td width="151" rowspan="2" valign="top"><img src="http://igem.semicolonsoftware.de/mediawiki/images/a/ab/Pathway-Symbol.jpg" width="149" height="141" /></td> | ||
<td><img src="http://igem.semicolonsoftware.de/mediawiki/images/1/19/Pathway-Header.gif" width="331" height="31" /></td> | <td><img src="http://igem.semicolonsoftware.de/mediawiki/images/1/19/Pathway-Header.gif" width="331" height="31" /></td> | ||
| Line 41: | Line 39: | ||
<tr> | <tr> | ||
<td valign="top"><div align="justify"> | <td valign="top"><div align="justify"> | ||
| - | <table | + | <table border="0" cellspacing="3" cellpadding="3"> |
<tr> | <tr> | ||
<td></html>Engineering an artificial pathway in a bacterial microcompartment to produce functional azobenzene-compounds, such as protein crosslinkers, tethered or soluble enzyme-modulators or optimizedligands for other molecular applications. [[Team:LMU-Munich/Pathway|more]]<html></td></tr> | <td></html>Engineering an artificial pathway in a bacterial microcompartment to produce functional azobenzene-compounds, such as protein crosslinkers, tethered or soluble enzyme-modulators or optimizedligands for other molecular applications. [[Team:LMU-Munich/Pathway|more]]<html></td></tr> | ||
| Line 49: | Line 47: | ||
</table> | </table> | ||
</td> | </td> | ||
| - | <td | + | <td align="center" valign="top" bgcolor="#FFFFFF"> |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
<table width="100%" border="0" cellspacing="2" cellpadding="2"> | <table width="100%" border="0" cellspacing="2" cellpadding="2"> | ||
<tr> | <tr> | ||
| Line 71: | Line 65: | ||
<a href="http://multivac.de/"><br /><img src="https://static.igem.org/mediawiki/2010/a/af/Multivac.jpg" width="240" height="71" border=0 /></a> | <a href="http://multivac.de/"><br /><img src="https://static.igem.org/mediawiki/2010/a/af/Multivac.jpg" width="240" height="71" border=0 /></a> | ||
<font size="1"> | <font size="1"> | ||
| - | |||
<br /> | <br /> | ||
</font> | </font> | ||
| Line 222: | Line 215: | ||
</td> | </td> | ||
</tr> | </tr> | ||
| - | + | <tr> | |
<td valign="top"><div align="center"> | <td valign="top"><div align="center"> | ||
<font size="2" face="verdana"> </font><br /><br /> | <font size="2" face="verdana"> </font><br /><br /> | ||
| Line 230: | Line 223: | ||
<td width="1%" align="right" valign="top" bgcolor="#FFFFFF"> </td> | <td width="1%" align="right" valign="top" bgcolor="#FFFFFF"> </td> | ||
</td> | </td> | ||
| + | |||
| + | <td valign="top"><div align="center"> | ||
| + | <font size="2" face="verdana"> </font><br /><br /> | ||
| + | <a href="http://www.gehealthcare.com/worldwide.html"><img src="https://static.igem.org/mediawiki/2010/7/74/GE_healthcare.jpg" width="138" height="107" border="0" /></a><font size="1"><br /><br /></font> | ||
| + | <a href="http://www.gehealthcare.com/worldwide.html"> | ||
| + | <font size="2" face="verdana">GE Healthcare</font></a></td> | ||
| + | <td width="1%" align="right" valign="top" bgcolor="#FFFFFF"> </td> | ||
| + | </td> | ||
| + | </tr> | ||
| + | <tr> | ||
<td valign="top"><div align="center"> | <td valign="top"><div align="center"> | ||
<font size="2" face="verdana"> </font><br /><br /> | <font size="2" face="verdana"> </font><br /><br /> | ||
| Line 239: | Line 242: | ||
<td valign="top"><div align="center"> | <td valign="top"><div align="center"> | ||
<font size="2" face="verdana"> </font><br /><br /> | <font size="2" face="verdana"> </font><br /><br /> | ||
| - | <a href="http://www. | + | <a href="http://www.ratiolab.com/"><img src="https://static.igem.org/mediawiki/2010/6/60/Ratiolab-Logo_II.jpg" width="197" height="71" border="0" /></a><font size="1"><br /><br /></font> |
| - | <a href="http://www. | + | <a href="http://www.ratiolab.com/"> |
| + | <font size="2" face="verdana">ratiolab-disposables for sciences</font></a></td> | ||
<td width="1%" align="right" valign="top" bgcolor="#FFFFFF"> </td> | <td width="1%" align="right" valign="top" bgcolor="#FFFFFF"> </td> | ||
</td> | </td> | ||
| - | |||
</tr> | </tr> | ||
| - | <tr></table> | + | <tr> |
| + | |||
| + | |||
| + | </table> | ||
Latest revision as of 20:36, 26 October 2010
ApoControl Biobrick Library: Possibilities of utilizing apoptosis as a clean and effective selection mark for manipulation in eucaryotic systems. Serves the improving of gen-expression in cell lines and the curtailing of cloning processure for large-scale screening. more
Engineering an artificial pathway in a bacterial microcompartment to produce functional azobenzene-compounds, such as protein crosslinkers, tethered or soluble enzyme-modulators or optimizedligands for other molecular applications. more
Center for Integrated Protein Science Munich LMU excellent
Multivac - Better Packaging
